Subsequent studies detected that most solid tumors expressed CD59 at a markedly high level compared to adjacent normal tissues, of which stage and prognosis were related to the CD59 levels, including breast cancer, non-small cell lung cancer, colon cancer, etc. [9–11]. Here, CD59 is linked to non-small cell lung carcinoma.